We are live on
!
Find out more
FP
Foundry Partners Portfolio holdings
AUM
$1.89B
1-Year Est. Return
9.84%
This Fund
S&P 500
This Quarter
Est. Return
+12.07%
1 Year Est. Return
+9.84%
3 Year Est. Return
+44.42%
5 Year Est. Return
+233.04%
10 Year Est. Return
+297.72%
AUM
$2.49B
AUM Growth
+$269M
(+12%)
Cap. Flow
+$39.2M
Cap. Flow
% of AUM
1.57%
Top 10 Holdings %
Top 10 Hldgs %
12.84%
Holding
410
New
26
Increased
190
Reduced
140
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$14.8M |
| 2 |
GSK
GSK
|
+$6.62M |
| 3 |
PDM
Piedmont Realty Trust
PDM
|
+$6.41M |
| 4 |
Johnson & Johnson
JNJ
|
+$4.61M |
| 5 |
SFS
Smart & Final Stores, Inc.
SFS
|
+$4.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TCF
TCF Financial Corporation
TCF
|
+$10.5M |
| 2 |
Intel
INTC
|
+$9.56M |
| 3 |
Chevron
CVX
|
+$6.96M |
| 4 |
Fulton Financial
FULT
|
+$5.2M |
| 5 |
BP
BP
|
+$4.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.93% |
| 2 | Industrials | 13.93% |
| 3 | Technology | 13.01% |
| 4 | Consumer Discretionary | 8.37% |
| 5 | Healthcare | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RP
251
DELISTED
RealPage, Inc.
RP
| $2.46M | 0.1% |
40,572
-2,714
| -6% | -$156K |
|
252
Orion Group Holdings
ORN
$514M
| $2.43M | 0.1% |
831,460
-61,034
| -7% | -$257K |
|
|
ZEUS
253
DELISTED
Olympic Steel
ZEUS
| $2.41M | 0.1% |
151,890
-36,500
| -19% | -$656K |
|
254
Neogen
NEOG
$2.05B
| $2.4M | 0.1% |
83,452
-5,070
| -6% | -$153K |
|
|
ESSA
255
DELISTED
ESSA Bancorp
ESSA
| $2.32M | 0.09% |
150,720
-29,675
| -16% | -$468K |
|
256
Euronet Worldwide
EEFT
$3B
| $2.31M | 0.09% |
16,190
-999
| -6% | -$125K |
|
|
JBTM
257
JBT Marel
JBTM
$7.11B
| $2.3M | 0.09% |
25,031
-1,751
| -7% | -$148K |
|
|
MDSO
258
DELISTED
Medidata Solutions, Inc.
MDSO
| $2.3M | 0.09% |
31,387
-2,156
| -6% | -$156K |
|
|
MLNX
259
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $2.29M | 0.09% |
19,382
-1,001
| -5% | -$101K |
|
260
Encompass Health
EHC
$11.2B
| $2.28M | 0.09% |
49,012
-3,038
| -6% | -$154K |
|
261
Harvard Bioscience
HBIO
$27.5M
| $2.26M | 0.09% |
52,417
-492
| -0.9% | -$17.8K |
|
262
NETGEAR
NTGR
$682M
| $2.25M | 0.09% |
67,922
+5,602
| +9% | +$203K |
|
263
Allot
ALLT
$376M
| $2.25M | 0.09% |
282,865
+76,700
| +37% | +$551K |
|
264
Dorman Products
DORM
$3.99B
| $2.2M | 0.09% |
24,987
-1,672
| -6% | -$145K |
|
265
Dick's Sporting Goods
DKS
$18.5B
| $2.17M | 0.09% |
58,930
-981
| -2% | -$35K |
|
|
AZPN
266
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $2.1M | 0.08% |
20,124
-1,078
| -5% | -$112K |
|
267
HealthEquity
HQY
$7.9B
| $2.01M | 0.08% |
27,196
-1,868
| -6% | -$131K |
|
268
NCS Multistage Holdings
NCSM
$120M
| $2M | 0.08% |
19,306
+1,027
| +6% | +$114K |
|
269
Healthcare Services Group
HCSG
$1.55B
| $1.97M | 0.08% |
59,697
-3,530
| -6% | -$135K |
|
270
Ramaco Resources Class A
METC
$686M
| $1.93M | 0.08% |
344,138
-102,255
| -23% | -$557K |
|
271
Coherent
COHR
$56.4B
| $1.91M | 0.08% |
51,263
+396
| +0.8% | +$14.6K |
|
|
RUTH
272
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $1.87M | 0.08% |
73,219
-5,030
| -6% | -$123K |
|
273
Northrim BanCorp
NRIM
$612M
| $1.87M | 0.08% |
217,400
-5,400
| -2% | -$48.6K |
|
274
Littelfuse
LFUS
$10.4B
| $1.82M | 0.07% |
9,998
-651
| -6% | -$120K |
|
275
Blackbaud
BLKB
$1.51B
| $1.82M | 0.07% |
22,771
-1,144
| -5% | -$83.9K |
|
Similar funds
ST
UH
PAME
TW
AP
MBA
SSB
CC
Foundry Partners's Q1 2019 Portfolio in Review
As of Q1 2019, Foundry Partners held 410 positions worth $2.49B, up 12% from $2.22B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Foundry Partners's Q1 2019 filing shows 26 new, 190 increased, 140 reduced and 24 closed positions. Its largest new stake was GSK: 132,408 shares worth $6.92M. The largest sale was TCF Financial Corporation, an estimated $10.5M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.
- Foundry Partners's largest Q1 2019 buy was GSK: 132,408 shares worth $6.92M.
- Foundry Partners added most to Philip Morris in Q1 2019, an estimated $14.8M increase.
- Foundry Partners's biggest Q1 2019 reduction was TCF Financial Corporation, cutting an estimated $10.5M.
- Foundry Partners fully exited Opus Bank Common Stock in Q1 2019, selling an estimated $4.66M.
- Foundry Partners's ten largest holdings make up 13% of its $2.49B portfolio in Q1 2019.
- Foundry Partners opened 26 new positions and closed 24 in Q1 2019.
- Foundry Partners's portfolio value rose 12% quarter-over-quarter to $2.49B.
Based on Foundry Partners's 13F filing for Q1 2019, filed 22 Apr 2019.